Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Invitae | RCV000114431 | SCV004285603 | uncertain significance | Amyotrophic lateral sclerosis type 21 | 2022-11-17 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on MATR3 function (PMID: 24686783, 26528920, 29109432, 30015619). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MATR3 protein function. ClinVar contains an entry for this variant (Variation ID: 126562). This missense change has been observed in individual(s) with clinical features of amyotrophic lateral sclerosis (PMID: 24686783; Invitae). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs587777301, gnomAD 0.0009%). This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 622 of the MATR3 protein (p.Thr622Ala). |
| OMIM | RCV000114431 | SCV000148374 | pathogenic | Amyotrophic lateral sclerosis type 21 | 2014-03-30 | no assertion criteria provided | literature only |